Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier as an assay to evaluate patients with lung nodules that are suspected of cancer. Veracyte offers genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions through its sales force across the US. It also commercializes its products in Brazil. Veracyte is headquartered in South San Francisco, California, the US.
Headquarters
United States of America
Address
6000 Shoreline Court, Suite 300, South San Francisco, California, 94080
Website
www.veracyte.com
Telephone
1 650 2436300
No of Employees
787
Industry
Medical Equipment
Ticker Symbol & Exchange
VCYT (NASD)
Revenue (2022)
$296.5M
35.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
51.6%
(2022 vs 2021)
Market Cap*
$1.6B
Net Profit Margin (2022)
XYZ
64.2%
(2022 vs 2021)
* As of and is in US$
Veracyte Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Afirma Thyroid FNA Analysis | Percepta |
| Bronchial Genomic Classifier | Prosigna |
| Gene Expression Classifier | Afirma |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Acquisitions/Mergers/Takeovers | In February, the company acquired C2i Genomics, Inc. |
| 2023 | Contracts/Agreements | In September, the company entered into a partnership with Gustave Roussy to help biopharmaceutical companies in the development of new cancer therapies. |
| 2021 | Contracts/Agreements | In June, the company entered into an agreement to acquire HalioDx, an immuno-oncology diagnostic company for US$317 million. |
Competitor Comparison
| Key Parameters | Veracyte Inc | Atara Biotherapeutics Inc | Lineage Cell Therapeutics Inc | GeneThera Inc | Lifelines Neurodiagnostic Systems Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | South San Francisco | Thousand Oaks | Carlsbad | Westminster | Troy |
| State/Province | California | California | California | Colorado | Illinois |
| No. of Employees | 787 | 308 | 78 | 2 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Robert S. Epstein | Chairman | Executive Board | 2015 | 67 |
| Bonnie H. Anderson | Chairman | Executive Board | - | 65 |
| Marc Stapley | Director; Chief Executive Officer | Executive Board | 2021 | 53 |
| Rebecca Chambers | Chief Financial Officer; Executive Vice President | Senior Management | 2021 | 45 |
| Jonathan Wygant | Chief Accounting Officer; Vice President | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward